G642-0465 Screening compound: N-{3-[4-acetyl-5-(2H-1,3-benzodioxol-5-yl)-4,5-dihydro-1,3,4-oxadiazol-2-yl]phenyl}benzamide

G642-0465 Screening compound: N-{3-[4-acetyl-5-(2H-1,3-benzodioxol-5-yl)-4,5-dihydro-1,3,4-oxadiazol-2-yl]phenyl}benzamide
G642-0465 Screening compound: N-{3-[4-acetyl-5-(2H-1,3-benzodioxol-5-yl)-4,5-dihydro-1,3,4-oxadiazol-2-yl]phenyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G642-0465
N-{3-[4-acetyl-5-(2H-1,3-benzodioxol-5-yl)-4,5-dihydro-1,3,4-oxadiazol-2-yl]phenyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G642-0465

Molecular Formula

C24H19N3O5 (C24 H19 N3 O5)

Compound Name

N-{3-[4-acetyl-5-(2H-1,3-benzodioxol-5-yl)-4,5-dihydro-1,3,4-oxadiazol-2-yl]phenyl}benzamide

IUPAC name

N-{3-[4-acetyl-5-(2H-13-benzodioxol-5-yl)-45-dihydro-134-oxadiazol-2-yl]phenyl}benzamide

SMILES

CC(N1N=C(c2cccc(NC(c3ccccc3)=O)c2)OC1c(cc1)cc2c1OCO2)=O

InChI

InChI=1S/C24H19N3O5/c1-15(28)27-24(18-10-11-20-21(13-18)31-14-30-20)32-23(26-27)17-8-5-9-19(12-17)25-22(29)16-6-3-2-4-7-16/h2-13,24H,14H2,1H3,(H,25,29)/t24-/m1/s1

InChI Key

YUGWSKBLLRAOFZ-XMMPIXPASA-N

MDL Number (MFCD)

MFCD15025131

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.226

Distribution Coefficient, logD

4.226

Water Solubility, LogSw

-4.35

Polar Surface Area

75.458

Acid Dissociation Constant (pKa)

11.58

Base Dissociation Constant (pKb)

-0.63

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

12.50

G642-0465 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with G642-0465 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G642-0465?
Check Price and Availability of G642-0465, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G642-0465 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G642-0465
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G642-0465
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G642-0465 available by request